• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
7
Views
1K
Anonymous
Replies
3
Views
2K
Anonymous
Replies
4
Views
2K
Anonymous
Replies
26
Views
4K
Anonymous
Replies
20
Views
2K
Anonymous
Replies
8
Views
2K
Anonymous
Replies
1
Views
578
Anonymous
Replies
1
Views
862
Anonymous
Replies
26
Views
6K
Anonymous
Replies
16
Views
2K
Anonymous
Replies
7
Views
1K
Anonymous
Replies
10
Views
2K
Anonymous
Replies
6
Views
2K
Anonymous
Replies
14
Views
2K
Anonymous
Replies
11
Views
2K
Anonymous
Replies
2
Views
834
Anonymous